Number of Shares
900,000.00
Current Holdings Value*
$9.02 Mil
% of Portfolio
0.37%
Total Estimate Gain
$207,000.00
% of Total Estimate Gain
2.30%

ARISTEIA CAPITAL, L.L.C.'s Drugs Made In America Acquisition Corp Holding Summary

As of 2025-03-31, ARISTEIA CAPITAL, L.L.C. held 900,000.00 shares of Drugs Made In America Acquisition Corp(DMAA), totaling $9.02 Mil. This investment constitutes 0.37% of their stock portfolio, and ARISTEIA CAPITAL, L.L.C. now holds 2.68% of the outstanding Drugs Made In America Acquisition Corp(DMAA) stock.

The initial trade took place in 2025Q1. And since then ARISTEIA CAPITAL, L.L.C. has made 1 purchases of DMAA, at an average price of $10.00, for a total of 900,000.00 shares. Based on historical transaction data and DMAA's current price of $10.23, ARISTEIA CAPITAL, L.L.C.'s estimated gain on his DMAA holdings is $207,000.00, reflecting a 2.30% gain to date.

ARISTEIA CAPITAL, L.L.C. DMAA ($10.23) Holding Chart

ARISTEIA CAPITAL, L.L.C. DMAA ($10.23) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1